Target intelligence / Profile preview

MicroRNA 3118-4 (MIR3118-4)

Target
MIR3118-4
Molecular classification
MicroRNA, Non-coding RNA
01

Overview

MicroRNA 3118-4 is a predicted human microRNA, a member of the class of small non-coding RNAs (about 20–24 nucleotides long) involved in post-transcriptional gene regulation by modulating mRNA stability or translation through binding to complementary sequences. MicroRNAs, including MIR3118-4, are processed from primary transcripts by the Drosha and Dicer endonucleases, and loaded into the RNA-induced silencing complex (RISC) to direct gene silencing. Although microRNAs as a class are involved in a wide range of biological processes and diseases, there is currently no specific functional, disease, or pharmacological data for MIR3118-4[1][2][6]. Important note: There is no published evidence linking MIR3118-4 to specific biological or disease roles, drug interactions, or biomarker status. Entry is likely computationally predicted and not yet experimentally validated, so the gene should be approached cautiously as a research or clinical target[1][6].

Other names
hsa-mir-3118-4MIR3118-4
02

Mechanism of action

Not applicable; in general, microRNAs are endogenous regulators that function by binding to complementary sequences on target mRNAs, inhibiting translation or promoting degradation

03

Biological functions

Post-transcriptional regulation of gene expressionmRNA stability and translation control
04

Disease associations

Other (no data specific for MIR3118-4; generally, microRNAs are implicated in cancer, development, cell differentiation, proliferation, apoptosis, but no evidence links this specific miRNA to a particular disease)
05

Safety considerations

None reported (no therapeutic or diagnostic interventions targeting this specific miRNA)
06

Interacting drugs

None known (no direct drugs identified for MIR3118-4 or its modulation)
07

Biomarkers

None known (no specific reports for MIR3118-4)

Beyond the preview

Go deeper on MicroRNA 3118-4 (MIR3118-4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3118-4 (MIR3118-4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call